ArticleFrontiers in medicine2026
Construction and internal validation of a machine learning model for predicting 30-day readmission after hip surgery.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and internally validate a machine learning (ML)-based model for predicting 30-day postoperative readmission after hip surgery using multidimensional perioperative data, and to evaluate its potential clinical utility. Methods: This single-center retrospective cohort study included 720 patients who underwent hip-related surgery at Guangxi Zhuang Autonomous Region People's Hospital between 2022 and 2025. Patients were randomly divided into training and test sets at a 7:3 ratio. Demographic characteristics, comorbidities, laboratory variables, anesthesia and temperature-management variables, surgical characteristics, and transfusion-related variables were extracted. Candidate predictors were first selected in the training set using the Boruta algorithm. Eleven base models and one stacking ensemble model were then developed using the selected features. Hyperparameters were optimized using 5-fold cross-validation combined with grid search. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (PRAUC), while decision curve analysis (DCA) and SHapley Additive exPlanations (SHAP) were used to assess clinical net benefit and model interpretability. Results: The overall 30-day readmission rate was 4.3%. In the test set, the XGBoost model achieved an AUC of 0.88 and a PRAUC of 0.53. Across commonly used threshold probabilities, XGBoost provided a higher net benefit than treat-all or treat-none strategies. SHAP analysis identified preoperative albumin, post-anesthesia care unit (PACU) temperature, warming duration, age, and heart failure as the leading predictors of readmission risk. Conclusion: The XGBoost-based ML model showed potential for predicting 30-day readmission after hip surgery and may provide supportive information for perioperative risk stratification and modifiable management strategies, particularly nutritional optimization and temperature management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.